Impact of reversible inhibitor binding to protein Arginine Deiminase Type 4 (PAD4): Molecular Dynamics Simulation and Mmpbsa Calculation
PAD4 catalyses the conversion of peptidylarginine into peptidylcitrulline. Overexpression of PAD4 and the peptidylcitrulline products have been reported in various diseases including rheumatoid arthritis and cancers. GSK199 is the first PAD4 selective reversible inhibitor discovered. The impact of G...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Proceeding Paper |
| 言語: | English English |
| 出版事項: |
2022
|
| 主題: | |
| オンライン･アクセス: | http://irep.iium.edu.my/107904/14/107904_Impact%20of%20reversible%20inhibitor%20binding%20to%20protein%20Arginine_abstract.pdf http://irep.iium.edu.my/107904/15/107904_Impact%20of%20reversible%20inhibitor%20binding%20to%20protein%20Arginine_slides.pdf http://irep.iium.edu.my/107904/ |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|